Nikhil wagle boston




















Citations: Fields: Med Medicine General. Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma. Assessing the clinical utility of cancer genomic and proteomic data across tumor types.

Nat Biotechnol. Citations: Fields: Bio Biotechnology. Colon cancer-derived oncogenic EGFR GS mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab. Mol Cancer. Citations: 14 Fields: Neo Neoplasms. Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.

The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. Citations: 73 Fields: Gen Genetics. Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.

Citations: 87 Fields: Neo Neoplasms. Clinicopathological features among patients with advanced human epidermal growth factorpositive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study. Clin Breast Cancer. Citations: 7 Fields: Neo Neoplasms. Clinical analysis and interpretation of cancer genome data.

Citations: 7 Translation: Humans Cells. A landscape of driver mutations in melanoma. Citations: Fields: Cel Cell Biology. Melanoma genome sequencing reveals frequent PREX2 mutations. High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing.

Dissecting therapeutic resistance to RAF inhibition in melanoma by tumor genomic profiling. Biomarker-based prediction of response to therapy for colorectal cancer: current perspective. Am J Clin Pathol. Citations: 29 Fields: Pat Pathology. Cardiac presentation of anaplastic large-cell lymphoma. A pdependent checkpoint pathway prevents rereplication.

Mol Cell. Re: Surveys identify barriers to participation in clinical trials. J Natl Cancer Inst. J Biol Chem. Citations: 44 Fields: Bio Biochemistry. Measuring the incremental cost of clinical cancer research.

J Mol Biol. Citations: 13 Fields: Mol Molecular Biology. Curr Oncol Rep. View in: PubMed ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors. View in: PubMed Response and acquired resistance to everolimus in anaplastic thyroid cancer. N Engl J Med. View in: PubMed Assessing the clinical utility of cancer genomic and proteomic data across tumor types.

Nat Biotechnol. View in: PubMed Colon cancer-derived oncogenic EGFR GS mutant identified by whole genome sequence analysis is dependent on asymmetric dimerization and sensitive to cetuximab. Mol Cancer. View in: PubMed Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine.

View in: PubMed Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium. View in: PubMed Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix. View in: PubMed Clinicopathological features among patients with advanced human epidermal growth factorpositive breast cancer with prolonged clinical benefit to first-line trastuzumab-based therapy: a retrospective cohort study.

Clin Breast Cancer. View in: PubMed Clinical analysis and interpretation of cancer genome data. View in: PubMed A landscape of driver mutations in melanoma. View in: PubMed High-throughput detection of actionable genomic alterations in clinical tumor samples by targeted, massively parallel sequencing. View in: PubMed Biomarker-based prediction of response to therapy for colorectal cancer: current perspective. Am J Clin Pathol. View in: PubMed Cardiac presentation of anaplastic large-cell lymphoma.

View in: PubMed A pdependent checkpoint pathway prevents rereplication. Mol Cell. Start and end your wedding planning journey with Boston Weddings' guide to the best wedding vendors in the city.

Search for: Search. I'm a scraper This search result is here to prevent scraping. Delivering the latest in style, inspiration, helpful tips and tricks, and everything else you need to know to plan the perfect New England wedding. Acquired HER2 mutations in ER metastatic breast cancer confer resistance to estrogen receptor-directed therapies. Nat Genet Cancer Cell ; Br J Cancer Oncologist Clin Pharmacol Ther J Clin Oncol Unraveling the clinicopathological features driving the emergence of mutations in metastatic breast cancer.

NPJ Breast Cancer ; Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers. Genet Med Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat Commun ; Sci Transl Med



0コメント

  • 1000 / 1000